One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract allows for robust antibody and T-cell responses where SARS-CoV-2 generally ...

Here, Park et al. analyse the serum IgG repertoires of two participants before and after immunization with an oral candidate vaccine based on an adenovirus vector-based platform carrying the VP1 ...

McMaster University has developed an inhaled COVID-19 vaccine and studies are starting phase-two of human trials.

How it works Convidencia is a viral vector vaccine using adenovirus five. With a viral vector, there is essentially a viral particle, which is programmed not to replicate. So, what is administered ...

Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, ...

Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...

The first-of-its-kind facility in India has received an investment of $75 million from the company to build it vertically ...

Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...

Immunotherapy has emerged as one of the major options for cancer treatment in the past decade. With the successful application of immune checkpoint inhibitors and the introduction of immune regulatory ...